New
Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
Advertisement
Advertisement
LFSCvsETF 2ETF Comparison
Choose a second ETF to run a side-by-side ETF comparison with LFSC, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
LFSC performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 03/12/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | LFSC ETF 2 | -5.12%– | -13.36%– | -7.57%– | +48.56%– | n/a– | n/a– |
| Flows | LFSC ETF 2 | +$6M– | +$6M– | +$5M– | +$16M– | -– | -– |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | LFSC ETF 2 | +22.88%– | +28.76%– | n/a– | n/a– |
| Max drawdown | LFSC ETF 2 | -13.77%– | -19.03%– | n/a– | n/a– |
| Max drawdown duration | LFSC ETF 2 | 77d– | 70d– | n/a– | n/a– |
Trading data
LFSC | ETF 2 | |
Last sale 3/13/2026 at 1:30 PM | $33.57 | – |
| Previous close 03/12/2026 | $33.82 | – |
| Consolidated volume 03/12/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Advertisement
Main metrics
Last update 3/13/2026 at 1:30 PM
Live
Closed
LFSC | ETF 2 | |
|---|---|---|
| Last price | $33.57 | – |
| 1D performance | -0.74% | – |
| AuM | $90.59 M | – |
| E/R | 0.79% | – |
Characteristics
LFSC | ETF 2 | |
|---|---|---|
| Management strategy | Active | – |
| Provider | Emerald Group | – |
| Benchmark | - | – |
| N° of holdings | 34 | – |
| Asset class | - | – |
| Trailing 12m distribution yield | Join | Join |
| Inception date | October 31, 2024 | – |
| ESG | No | – |
Advertisement
Exposure
Countries
LFSC
USA
88.44%
Other
11.56%
ETF 2
Sectors
LFSC
Health Care
86.26%
Other
13.74%
ETF 2
Advertisement
Diversification
LFSC
Total weight of top 15 holdings out of 15
68.94%
ETF 2
–
Top 15 holdings
Data as of January 31, 2026
LFSC
COGENT BIOSCIENCES
9.06%
LIVANOVA
6.76%
GUARDANT HEALTH INC
5.62%
MIRUM PHARMACEUTICALS INC
5.37%
TRANSMEDICS GROUP
5.18%
WAVE LFE SCIEN
4.81%
TRAVERE THERAPEUTICS INC
4.77%
BRIDGEBIO PHARMA
3.92%
SAVARA INC
3.82%
ICU MEDICAL
3.60%
KALVISTA PHARMACEUTICALS INC
3.59%
UTD THERAPEUT
3.56%
US00773J2024
3.44%
MADRIGAL PHARMACEUTICALS INC
2.86%
ACADIA PHARMACEUTICALS
2.58%
ETF 2
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
Advertisement
Advertisement
Advertisement
Webcast on Demand
Calamos Investments Powers the Next Phase of the Autocallable Revolution
Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.
Accepted for 1 CE Credit
